Market Overview

KemPharm (NYSE: KMPH)

0.26 +0.06 (27.82%)

Analyst Ratings

DateResearch FirmActionCurrentPT
5/20/20HC Wainwright & Co.ReiteratesBuy1.5
11/20/19H.C. WainwrightReiteratesBuy2.5
9/05/19Roth CapitalDowngradesNeutral1.1
6/19/19H.C. WainwrightInitiates Coverage OnBuy3.0
5/23/18Janney CapitalInitiates Coverage OnBuy17.0
2/26/18Canaccord GenuityMaintainsBuy11.0
12/20/16Canaccord GenuityAssumesBuy9.0
9/18/15OppenheimerMaintainsOutperform28.0
7/02/15Canaccord GenuityMaintainsBuy24.0
6/15/15Canaccord GenuityMaintainsBuy22.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter